Mexico's medical device market represents a critical gateway to Latin America, driven by its growing healthcare expenditure and robust industrial sector. However, staying abreast of the evolving regul...
Mexico's medical device market represents a critical gateway to Latin America, driven by its growing healthcare expenditure and robust industrial sector. However, staying abreast of the evolving regulatory landscape, particularly with significant reforms on the horizon, is paramount for success. Biotech and medtech companies looking to introduce innovative devices to this dynamic market must understand the intricacies of the COFEPRIS regulatory framework. These changes, often termed the 'Plan Mexico Medical Device Registration Reform,' signal a more streamlined yet equally stringent approach to device approval. At bioaccess®, we specialize in guiding companies through the complexities of Latin American regulatory environments. Our deep understanding of local nuances, particularly concerning COFEPRIS and other regional bodies like ANVISA in Brazil and INVIMA in Colombia, positions us as your trusted partner. This article will delve into the proposed and implemented reforms to Mexico's …